Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Eastvale’s Biotech Scene: How Local Regulations Influence Consultancy Services

Dec 06, 2025

Eastvale has emerged as a vibrant hub for the biotechnology industry, attracting a wide range of companies and professionals. The city's approach to local regulations plays a crucial role in shaping the landscape for consultancy services within this sector. Understanding these regulations is essential for consultants who aim to guide biotech companies through the complexities of compliance and innovation.

biotech laboratory

The Importance of Local Regulations

Local regulations in Eastvale are designed to ensure that biotech firms operate safely and ethically. These regulations cover various aspects, including environmental impact, safety protocols, and research ethics. For consultants, staying updated with these rules is vital to provide accurate and effective guidance to businesses.

Eastvale’s regulatory framework is known for being both stringent and supportive, promoting innovation while ensuring public safety. This balance is essential for consultants who must navigate these rules to help companies thrive without compromising on compliance.

Consultancy Services in Demand

With the complexity of biotech regulations, the demand for consultancy services in Eastvale has grown significantly. Consultants offer expertise in areas such as regulatory compliance, strategic planning, and market entry strategies. Their role is to provide tailored advice that aligns with both local regulations and business objectives.

consultation meeting

Consultants are also pivotal in helping startups and established firms understand the nuances of Eastvale’s regulatory environment. They act as intermediaries, ensuring that companies can focus on innovation while remaining compliant with all necessary regulations.

Key Regulatory Challenges

One of the main challenges biotech companies face in Eastvale is navigating the intricate regulatory landscape. This includes obtaining necessary permits, adhering to safety standards, and ensuring ethical practices in research and development.

Consultants play a crucial role in overcoming these challenges by offering insights and solutions tailored to each company's unique needs. They help businesses anticipate potential regulatory hurdles and develop strategies to address them effectively.

biotech research

Opportunities for Growth

Despite the challenges, Eastvale’s regulatory environment offers numerous opportunities for growth in the biotech sector. The city’s commitment to supporting innovation creates a fertile ground for new ideas and technologies to flourish.

Consultants can leverage these opportunities by helping companies align their goals with regulatory requirements, allowing them to innovate confidently and sustainably. This synergy between compliance and creativity is what sets Eastvale apart as a leading biotech hub.

The Future of Biotech Consultancy in Eastvale

As Eastvale continues to evolve, the role of consultancy services in the biotech industry will become even more significant. The need for expert guidance in navigating complex regulations is expected to grow, providing consultants with ample opportunities to make a meaningful impact.

By staying informed about regulatory changes and understanding the unique needs of biotech companies, consultants can ensure that Eastvale remains at the forefront of innovation while maintaining the highest standards of safety and ethics.